JCI vs SILO · P/E 44, rev $23.60B vs rev $18.0K
Johnson Controls International PLC (JCI) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. SILO currently screens at market cap $4.4M.
Not investment advice. Open the JCI and SILO stock pages for the full models.
Not investment advice.